Effect of changes in serum levels of endogenous hydrogen sulfide on fracture healing: a prospective cohort study

The effect of endogenous hydrogen sulfide in calcium and phosphorus loss after fracture

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900026045

Enrollment

Unknown

Registered

2019-09-19

Start date

2019-10-01

Completion date

Unknown

Last updated

2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture

Interventions

normal healing group + delayed healing group:N/A

Eligibility

Sex/Gender

All

Age

7 Years to 77 Years

Inclusion criteria

Inclusion criteria: Fracture patients: From October 1, 2018 to December 31, 2020, they were hospitalized in the orthopaedics department of our hospital. The clinical data were complete. There were definite spine or limb fractures.

Exclusion criteria

Exclusion criteria: Fracture patients: Oral or intravenous electrolyte supplementation (except free diet) was used from the time of fracture to the time of blood collection.

Design outcomes

Primary

Measure	Time frame
Serum hydrogen sulfide;Glucocorticoid content;	—

Secondary

Measure	Time frame
Serum calcium;Serum Phosphorus;Urine calcium;urine phosphorus;creatinine;	—

Countries

China

Contacts

Public ContactLiao Feng

Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital

liaofeng@uestc.edu.cn+86 15108423821

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026